Their inclusion in studies has undoubtedly increased understanding of biomarkers for cognitive function and cognitive disorder, in this case, demonstrating that individual differences, such as APOE phenotypes, may have survival and development benefits. The gene discussed is APOE; the disease is cognitive disorder.